Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplantation · 2023
DOI: 10.1038/s41409-023-02027-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone Marrow Transplantation, 2023. Verfasst von Enrico Maffini und 20 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto "L. e A. Seràgnoli", Bologna, Italy. enrico.maffini@aosp.bo.it. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto "L. e A. Seràgnoli", Bologna, Italy. enrico.maffini@aosp.bo.it.
- EBMT ALWP Statistical Unit, Saint Antoine Hospital, Sorbonne University, Paris, France.
- Programme de Transplantation et Therapie Cellulaire, Centre de Recherche en Cancerologie de Marseille, Institut Paoli Calmettes, Marseille, France.
- Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University hospital Leipzig, Leipzig, Germany.
- Bone Marrow Transplant Unit L 4043, National University Hospital Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Enrico Maffini, Jacques-Emmanuel Galimard, Nicolaus Kröger, Charles Craddock, Patrice Chevallier, Johan Maertens, Fabio Ciceri, Jaime Sanz, Alexandros Spyridonidis, Francesco Lanza, Mohamad Mohty
Zitieren
APA
Maffini, E., Ngoya, M., Galimard, J. E., Harbi, S., Kröger, N., Platzbecker, U., Sengeloev, H., Craddock, C., Potter, V., Choi, G., Chevallier, P., Stölzel, F., Tholouli, E., Maertens, J., Ciceri, F., Cornelissen, J., Sanz, J., Spyridonidis, A., Lanza, F., …, & Mohty, M. (2023). Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. https://doi.org/10.1038/s41409-023-02027-y
Vancouver
Maffini E, Ngoya M, Galimard JE, Harbi S, Kröger N, Platzbecker U, et al. Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 2023. doi:10.1038/s41409-023-02027-y
BibTeX
@article{Maffini2023,
author = {Maffini, Enrico and Ngoya, Maud and Galimard, Jacques-Emmanuel and Harbi, Samia and Kröger, Nicolaus and Platzbecker, Uwe and Sengeloev, Henrik and Craddock, Charles and Potter, Victoria and Choi, Goda and Chevallier, Patrice and Stölzel, Friedrich and Tholouli, Eleni and Maertens, Johan and Ciceri, Fabio and Cornelissen, Jan and Sanz, Jaime and Spyridonidis, Alexandros and Lanza, Francesco and Nagler, Arnon and Mohty, Mohamad},
title = {Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)},
journal = {Bone Marrow Transplantation},
year = {2023},
doi = {10.1038/s41409-023-02027-y}
}
EUVIMED